Risk Factors for No-Reflow in Patients with ST-Elevation Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Case-Control Study

Table 2

Univariable analysis for no-reflow.

Variables	Univariable analysis
	OR (95% CI)
Clinical data
Age	1.015 (1.000–1.030)	0.052
Male	1.171 (0.779–1.762)	0.448
Hypertension	1.141 (0.825–1.577)	0.426
Diabetes mellitus	1.197 (0.819–1.749)	0.353
Smoking	0.983 (0.694–1.393)	0.923
Prior PCI	0.638 (0.312–1.307)	0.220
Preinfarction angina	1.158 (0.836–1.605)	0.377
Medication before MI
Aspirin	0.872 (0.502–1.513)	0.625
ACEI	1.241 (0.752–2.050)	0.398
β-Blocker	1.558 (0.781–3.108)	0.208
Calcium channel blockers	1.106 (0.754–1.624)	0.606
Statin	1.238 (0.466–3.290)	0.669
Time-to-hospital admission	0.985 (0.976–0.995)	0.002
Physical findings on admission
Systolic blood pressure	0.995 (0.987–1.003)	0.209
Diastolic blood pressure	1.000 (0.987–1.013)	0.992
Heart rate	1.026 (1.016–1.037)	<0.001
Laboratory indicators
Plasma glucose	1.088 (1.042–1.135)	<0.001
hsCRP	1.024 (1.009–1.039)	0.001
PAB	0.026 (0.002–0.385)	0.008
hsCRP/PAB	1.005 (1.003–1.008)	<0.001
Albumin	0.995 (0.973–1.019)	0.701
hsCRP/albumin	1.551 (0.963–2.499)	0.071
Neutrophil count	1.172 (1.117–1.229)	<0.001
LDL-C	0.989 (0.930–1.052)	0.733
Triglycerides	1.013 (0.958–1.070)	0.659
Killip classes >1	0.648 (0.433–0.970)	0.035
Treatment before or during the procedure
Glycoprotein IIb/IIIa inhibitor	1.608 (0.936–2.764)	0.086
Intraaortic balloon pump	0.203 (0.128–0.320)	<0.001
Angiography
Multivessel disease	1.174 (0.710–1.702)	0.396
Infarct-related artery	0.557 (0.325–0.954)	0.033
Procedure
Aspiration thrombectomy	0.247 (0.169–0.361)	<0.001
After dilation	1.302 (0.940–1.801)	0.112
Stent diameter	1.114 (0.894–1.388)	0.334
Total stent length	1.002 (0.991–1.012)	0.752

PCI, percutaneous coronary intervention; MI, myocardial infarction; ACEI, angiotensin-converting enzyme inhibitor; hsCRP, high-sensitivity C-reactive protein; PAB, prealbumin; LDL-C, low-density lipoprotein cholesterol.